Browsing "1. Journal Papers" by Identifier : ANNALS OF ONCOLOGY, Vol.33(suppl 2) : S29-S30, 2022-04

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 1 of 1

This table browses all dspace content
Issue DateTitleJournal Title
2022Patient reported outcomes (PROs) with 1L durvalumab (D), with or without tremelimumab (T), plus chemotherapy (CT) in metastatic (m) NSCLC: Results from POSEIDONANNALS OF ONCOLOGY
1

Browse

Links